Literature DB >> 10706545

Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning.

E Totsuka1, J J Fung, A Urakami, N Moras, T Ishii, K Takahashi, S Narumi, K Hakamada, M Sasaki.   

Abstract

Hepatic allografts from donors who have suffered a brief cardiopulmonary arrest may sustain ischemic damage before organ procurement. However, there is no reported correlation between donor cardiopulmonary arrest and hepatic allograft dysfunction. On the other hand, brief ischemia-reperfusion injury has been shown experimentally to result in protection in several organ models. Induction of ischemic tolerance has been called ischemic preconditioning. Our objective was to study the influence of brief donor cardiopulmonary arrest on hepatic allograft outcome in human liver transplantation. Between May 1997 and July 1998, 181 consecutive orthotopic liver transplant (OLT) cases were divided into 2 groups based on the occurrence of donor cardiopulmonary arrest. Group A consisted of 37 donors who suffered a cardiopulmonary arrest. Group B consisted of the remaining 144 patients. Liver graft survival within 90 days of OLT and early postoperative graft function were analyzed. Although there was significant liver damage resulting from circulatory failure during cardiopulmonary arrest before organ procurement in group A, graft survival was not affected. After OLT, the mean peak aspartate transaminase and alanine transaminase concentrations in group A (1, 444.1 and 718.2 U/L) were significantly lower than those in group B (2,382.8 and 1,507.3 U/L) (P <.05). Experiences of brief cardiopulmonary arrest in organ donors did not affect post-OLT hepatic allograft survival and function. Although the liver function tests are elevated in an organ donor, the hepatic allograft is suitable for OLT if the liver damage is induced by brief donor cardiopulmonary arrest.

Entities:  

Mesh:

Year:  2000        PMID: 10706545     DOI: 10.1002/hep.510310305

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia/reperfusion injury in rat liver graft.

Authors:  Ming-Qing Xu; Xiu-Rong Shuai; Mao-Lin Yan; Ming-Man Zhang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 2.  Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages.

Authors:  M I Prince; M Hudson
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

3.  Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance.

Authors:  Paola Andreani; Emir Hoti; Sofia de la Serna; Davide degli Esposti; Mylène Sebagh; Antoinette Lemoine; Philippe Ichai; Fauzi Saliba; Denis Castaing; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

4.  Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang.

Authors:  Daniel Azoulay; Massimo Del Gaudio; Paola Andreani; Philippe Ichai; Mylène Sebag; René Adam; Olivier Scatton; Bao Yan Min; Valérie Delvard; Antoinette Lemoine; Henri Bismuth; Denis Castaing
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

5.  Safe time to warm ischemia and posttransplant survival of liver graft from non-heart-beating donors.

Authors:  Xiao-Shun He; Yi Ma; Lin-Wei Wu; Wei-Qiang Ju; Jin-Lang Wu; Rui-De Hu; Gui-Hua Chen; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

6.  Use of lung allografts from brain-dead donors after cardiopulmonary arrest and resuscitation.

Authors:  Anthony W Castleberry; Mathias Worni; Asishana A Osho; Laurie D Snyder; Scott M Palmer; Ricardo Pietrobon; R Duane Davis; Matthew G Hartwig
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

7.  Ischemic preconditioning attenuates capillary no-reflow and leukocyte adherence in postischemic pancreatitis.

Authors:  R Obermaier; E von Dobschuetz; O Drognitz; U T Hopt; S Benz
Journal:  Langenbecks Arch Surg       Date:  2004-01-09       Impact factor: 3.445

8.  Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.

Authors:  Virginia Fernández; Gladys Tapia; Luis A Videla
Journal:  World J Hepatol       Date:  2012-04-27

9.  Impact of Deceased Donor Cardiac Arrest Time on Postpancreas Transplant Graft Function and Survival.

Authors:  Joel R Schroering; Richard S Mangus; John A Powelson; Jonathan A Fridell
Journal:  Transplant Direct       Date:  2018-08-21

10.  Impact of Donor Pre-Procurement Cardiac Arrest (PPCA) on Clinical Outcomes in Liver Transplantation.

Authors:  Richard S Mangus; Joel R Schroering; Jonathan A Fridell; Chandrashekhar A Kubal
Journal:  Ann Transplant       Date:  2018-11-20       Impact factor: 1.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.